According to the research report titled ‘Mesenchymal Stem Cells Market, [By Source; By Application; By Region]: Market Size & Forecast, 2018 – 2026’, available with Market Study Report, global mesenchymal stem cells market reached a valuation of USD 1,335.1 million in the year 2017 and is expected to grow with a CAGR off 7% during the forecast period, subsequently accounting for USD 2,518.5 million by the year 2026.
 

Escalating investments towards R&D activities, development of innovative treatment options for several chronic conditions such as cancer and supportive government regulations which promote the use of stem cells are key factors driving the growth of global mesenchymal stem cells market.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/1695294/
 

It is to be noted that mesenchymal stem cells are typically found in the bone marrow in adults. These cells can also be found in fallopian tube, cord blood, and peripheral blood tissues. Increased pervasiveness of chronic conditions such as bone & cartilage disorders, autoimmune disease, and cancer are positively influencing worldwide mesenchymal stem cells industry outlook.  
 

Mesenchymal stem cells are usually used to heal damaged tissues without causing any pain. Thus, growing product demand as an efficient therapy alternative for knee replacement in tandem with growing geriatric population are adding traction to the overall market size.
 

From the regional point of view, North America accounted for the highest share in global mesenchymal stem cells industry in the recent past. On the other hand, Asia-Pacific is expected to emerge as a major revenue generator in the ensuing years. Improving healthcare infrastructure in India and China is favoring the market scenario in Asia-Pacific.
 

The competitive landscape of global mesenchymal stem cells market is defined by major companies such as Stemedica Cell Technologies Inc., BrainStorm Cell Therapeutics Inc., Celprogen Inc., Stemcell Technologies Inc., Cytori Therapeutics Inc., Axol Bioscience Ltd., Cyagen Biosciences Inc., and Cell Applications Inc. among others.